April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Radiotherapy
Author Affiliations & Notes
  • Ido Didi Fabian
    The Goldschleger Eye Institute, The Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel
  • Vicktoria Vishnevskia-Dai
    The Goldschleger Eye Institute, The Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel
  • Michael Belkin
    The Goldschleger Eye Institute, The Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel
  • Ofira Zloto
    The Goldschleger Eye Institute, The Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel
  • Footnotes
    Commercial Relationships Ido Didi Fabian, None; Vicktoria Vishnevskia-Dai, None; Michael Belkin, None; Ofira Zloto, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5089. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ido Didi Fabian, Vicktoria Vishnevskia-Dai, Michael Belkin, Ofira Zloto; A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Radiotherapy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5089.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To examine the feasibility of a novel technique for plaque radiotherapy placement and removal, using fibrin glue and urokinase, respectively, to explore quantitative variables, and compare these to conventional suturing.

 
Methods
 

The feasibility of the surgical technique was tested in 6 enucleated porcine eyes. Plaques without radioactive seeds were placed on the sclera beneath the conjunctiva, fibrin glue was then applied on the plaque, covering it and its immediate environment (Figure 1A). The eyes were then submerged in plasma for 3 days. Thereafter, attempts were made to dissolve the glue and release the plaque using urokinase (10,000 units/10cc normal saline (NS)) or NS only, by a surgeon masked as to the nature of the dissolving fluid (Figure 1B). In a second group of eyes, adhesion strength was measured using a system constructed of a tension transducer, a pulley, a transmission wire and an electrical winch (Figure 2). The eyes were prepared as described above, after which they were submerged in plasma for 5 days (replaced every 36 hours). Measurements were performed subsequently on 5 glued eyes and 5 eyes in which the plaques were sutured, and the results were recorded and analyzed.

 
Results
 

One to 2 ml of fibrin glue was used in order to fix each plaque in place. In all cases the urokinase syringe was identified, as the NS had no effect on the plaque-glue-eye complex, whereas the urokinase dissolved the adhesion between the glue layer and surrounding tissues. The plaques were then delivered out easily, after which a glue "blanket" was removed in full. No tissue defects were observed thereafter. The volume of urokinase used per eye was 0.38±0.08 ml. In the second part, the weights needed to detach the plaques were 0.35±0.17 kg and 0.41±0.08 kg for the glue and sutures, respectively (P=0.59).

 
Conclusions
 

A novel biological adhesive and dissolvent system using fibrin glue and urokinase was found to be a feasible technique for plaque surgery in an ex-vivo animal model. Fibrin glue was as durable as sutures, but may be preferable to the use of sutures in enabling precise plaque positioning and in the lack of complications, such as globe perforation or plaque displacement. Further in-vivo experiments are warranted.

 
 
A - application of fibrin glue. The blue color is due to food coloring (for visualization purposes) B - application of urokinase
 
A - application of fibrin glue. The blue color is due to food coloring (for visualization purposes) B - application of urokinase
 
 
adhesion strength measuring system
 
adhesion strength measuring system
 
Keywords: 744 tumors  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×